Membrane-anchored peptide inhibits human immunodeficiency virus entry

被引：101
作者：
Hildinger, M
Dittmar, MT
Schult-Dietrich, P
Fehse, B
Schnierle, BS
Thaler, S
Stiegler, G
Welker, R
von Laer, D [1 ]
机构：
[1] Georg Speyer Haus, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany
[2] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany
[3] Univ Hamburg, Krankenhaus Eppendorf, Zentrum Knochenmarktransplantat, D-20251 Hamburg, Germany
[4] Inst Appl Microbiol, A-1190 Vienna, Austria
来源：
JOURNAL OF VIROLOGY | 2001年 / 75卷 / 06期
关键词：
D O I：
10.1128/JVI.75.6.3038-3042.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Peptides derived from the heptad repeats of human immunodeficiency virus (HIV) gp41 envelope glycoprotein, such as T20, can efficiently inhibit HIV type 1 (HIV-1) entry. In this study, replication of HTV-1 was inhibited more than 100-fold in a T-helper cell line transduced with a retrovirus vector expressing membrane-anchored T20 on the cell surface. Inhibition was independent of coreceptor usage.
引用
收藏
页码：3038 / 3042
页数：5
相关论文
共 30 条
  • [1] GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION
    BUCHACHER, A
    PREDL, R
    STRUTZENBERGER, K
    STEINFELLNER, W
    TRKOLA, A
    PURTSCHER, M
    GRUBER, G
    TAUER, C
    STEINDL, F
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 359 - 369
  • [2] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273
  • [3] Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
    Chun, TW
    Engel, D
    Mizell, SB
    Hallahan, CW
    Fischette, M
    Park, S
    Davey, RT
    Dybul, M
    Kovacs, JA
    Metcalf, JA
    Mican, JM
    Berrey, MM
    Corey, L
    Lane, HC
    Fauci, AS
    [J]. NATURE MEDICINE, 1999, 5 (06) : 651 - 655
  • [4] HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM
    COSSET, FL
    TAKEUCHI, Y
    BATTINI, JL
    WEISS, RA
    COLLINS, MKL
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (12) : 7430 - 7436
  • [5] Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
    Eckert, DM
    Malashkevich, VN
    Hong, LH
    Carr, PA
    Kim, PS
    [J]. CELL, 1999, 99 (01) : 103 - 115
  • [6] Selective immunoaffinity-based enrichment of CD34(+) cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (Delta LNGFR) gene
    Fehse, B
    Uhde, A
    Fehse, N
    Eckert, HG
    Clausen, J
    Ruger, R
    Koch, S
    Ostertag, W
    Zander, AR
    Stockschlader, M
    [J]. HUMAN GENE THERAPY, 1997, 8 (15) : 1815 - 1824
  • [7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
    Finzi, D
    Blankson, J
    Siliciano, JD
    Margolick, JB
    Chadwick, K
    Pierson, T
    Smith, K
    Lisziewicz, J
    Lori, F
    Flexner, C
    Quinn, TC
    Chaisson, RE
    Rosenberg, E
    Walker, B
    Gange, S
    Gallant, J
    Siliciano, RF
    [J]. NATURE MEDICINE, 1999, 5 (05) : 512 - 517
  • [8] Capture of an early fusion-active conformation of HIV-1 gp41
    Furuta, RA
    Wild, CT
    Weng, YK
    Weiss, CD
    [J]. NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) : 276 - 279
  • [9] In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A
    Grättinger, M
    Hohenberg, H
    Thomas, D
    Wilk, T
    Müller, B
    Kräusslich, HG
    [J]. VIROLOGY, 1999, 257 (01) : 247 - 260
  • [10] Grignani F, 1998, CANCER RES, V58, P14
123